Clinical Trials News

Monoclonal antibody for COVID meets safety endpoints in phase 3 trial

Monoclonal antibody for COVID meets safety endpoints in phase 3 trial

Clinical Trials News

Publication date: Oct 02, 2026 Internal Server Error Internal Server Error

Concepts
Keywords

Antibody

Based

Comirnaty

Covid

Group

Hypersensitivity

Invivyd

Isr

Monoclonal

Participants

Phase

Reaction

Safety

Trial

Vyd2311

Semantics

Type
Source
Name

disease
MESH
included

disease
MESH
injection site reaction

disease
MESH
COVID-19

disease
MESH
hypersensitivity

pathway
REACTOME
Release

Original Article

Read more